Survival analysis further demonstrated that patients with HNSCC exhibiting high TXNDC12 expression levels experienced significantly poorer overall survival compared with those with low expression across independent cohorts (Fig. 1j, k). The gene discussed is TXNDC12; the disease is head and neck squamous cell carcinoma.